–        Real World Study Compared Over 150,000 Adult & Pediatric Patients ––        Caldolor Associated with Fewer Adverse Drug Reactions ––        Caldolor also Improved Healthcare Utilization –NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ -- Specialty pharmaceutical company Cumberland Pharmaceuticals (Nasdaq: CPIX) today announced the publication of new real-world outcomes research demonstrating the safety and healthcare resource advantages of its Caldolor (ibuprofen) injection over ketorolac in both adult ...